Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 18,447 shares at $50.00 ($901K) on 2021-01-07, disclosed to the SEC on 2021-01-11.
Open-market sale of $901k RGNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.00 | 10,998 | $550K | 61.0% |
| 2 | $46.45 | 2,460 | $114K | 12.7% |
| 3 | $47.49 | 2,208 | $105K | 11.6% |
| 4 | $47.49 | 2,208 | $105K | 11.6% |
| 5 | $48.15 | 573 | $28K | 3.1% |
| Total | $48.87 avg | 18,447 |
| $901K |
| 100% |
| Filing → |
| RGNX | SELL | 2022-08-03 | $75K | — | Filing → |
| RGNX | SELL | 2022-07-15 | $274K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |